Ketamine Recruiting Phase 4 Trials for Depressive Disorder, Treatment-Resistant Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02610712Clinical Trial of the Use of Ketamine in Treatment Resistant Depression